Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-14 9:05 pm Purchase | 13G | ORCHARD THERAPEUTICS PLC ADS N ORTX | Blue Owl Capital Holdings LP | 15,596,600 6.85% | 15,596,600 (New Position) | View |
| 2024-02-14 6:35 pm Unchanged | 13G | ORCHARD THERAPEUTICS PLC ADS N ORTX | RA CAPITAL MANAGEMENT L.P. | 0 0% | 0 (Unchanged) | View |
| 2024-02-12 12:03 pm Sale | 13G | ORCHARD THERAPEUTICS PLC ADS N ORTX | FMR LLC | 0 0% | -8,611,360 (Position Closed) | View |
| 2024-02-09 09:28 am Sale | 13G | ORCHARD THERAPEUTICS PLC ADS N ORTX | FMR LLC | 8,611,360 6.961% | -15 (-0.00%) | View |
| 2024-02-08 7:01 pm Purchase | 13G | ORCHARD THERAPEUTICS PLC ADS N ORTX | Beryl Capital Management LLC | 15,614,990 6.9% | 2,114,990 (+15.67%) | View |
| 2023-10-16 4:01 pm Purchase | 13G | ORCHARD THERAPEUTICS PLC ADS N ORTX | Beryl Capital Management LLC | 13,500,000 5.9% | 13,500,000 (New Position) | View |
| 2023-04-10 11:39 am Sale | 13G | ORCHARD THERAPEUTICS PLC ADS ORTX | FEDERATED HERMES INC. FHI | 840,169 4.57% | -7,561,518 (-90.00%) | View |
| 2023-03-20 4:43 pm Purchase | 13G | ORCHARD THERAPEUTICS PLC ADS N ORTX | Deep Track Capital LP | 19,125,150 9.99% | 19,125,150 (New Position) | View |
| 2023-03-20 4:30 pm Purchase | 13G | ORCHARD THERAPEUTICS PLC ADS ORTX | RA CAPITAL MANAGEMENT L.P. | 18,564,300 9.99% | 18,564,300 (New Position) | View |
| 2023-02-13 12:06 pm Purchase | 13G | ORCHARD THERAPEUTICS PLC ADS ORTX | CHI Advisors LLC | 7,987,396 6.3% | 1,537,540 (+23.84%) | View |
| 2023-02-10 10:07 am Sale | 13G | ORCHARD THERAPEUTICS PLC ADS ORTX | Flynn James E | 3,161,707 2.5% | -3,787,709 (-54.50%) | View |
| 2023-02-09 09:19 am Purchase | 13G | ORCHARD THERAPEUTICS PLC ADS ORTX | Zentree Investments Ltd | 15,960,561 12.598% | 3,042,443 (+23.55%) | View |
| 2023-02-01 11:25 am Purchase | 13G | ORCHARD THERAPEUTICS PLC ADS ORTX | FEDERATED HERMES INC. FHI | 8,401,687 6.63% | 91,828 (+1.11%) | View |
| 2022-12-20 06:01 am Purchase | 13G | ORCHARD THERAPEUTICS PLC ADS ORTX | Zentree Investments Ltd | 12,918,118 10.197% | 6,440,646 (+99.43%) | View |
| 2022-11-14 4:43 pm Sale | 13G | ORCHARD THERAPEUTICS PLC ADS ORTX | RA CAPITAL MANAGEMENT L.P. | 0 0% | -9,694,789 (Position Closed) | View |
| 2022-09-09 10:11 am Purchase | 13G | ORCHARD THERAPEUTICS PLC ADS ORTX | Zentree Investments Ltd | 6,477,472 5.122% | 6,477,472 (New Position) | View |
| 2022-05-09 12:55 pm Sale | 13G | ORCHARD THERAPEUTICS PLC ADS ORTX | Artisan Partners Limited Partnership | 3,322,737 2.6% | -6,493,371 (-66.15%) | View |
| 2022-02-14 4:11 pm Sale | 13G | ORCHARD THERAPEUTICS PLC ADS ORTX | RA CAPITAL MANAGEMENT L.P. | 9,694,789 7.7% | -2,620,424 (-21.28%) | View |
| 2022-02-14 1:26 pm Purchase | 13G | ORCHARD THERAPEUTICS PLC ADS ORTX | FEDERATED HERMES INC. FHI | 8,309,859 6.62% | 8,309,859 (New Position) | View |
| 2022-02-11 4:12 pm Unchanged | 13G | ORCHARD THERAPEUTICS PLC ADS ORTX | Flynn James E | 6,949,416 5.54% | 0 (Unchanged) | View |